Argos confirms plans to hire 236 in Durham, invest $57 in new biomanufacturing plant

There’s been a lot of speculation the last few months about when – and where – Durham-based Argos Therapeutics would be building its expensive new biomanufacturing plant for the production of its the immunotherapy drug candidates currently in phase three trials with the FDA...